Details for Netherlands Supplementary Protection Certificate: 301053
Netherlands Supplementary Protection Certificate: 301053
| Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2081595 | 301053 | Netherlands | PRODUCT NAME: DARATUMUMAB, BORTEZOMIB, THALIDOMIDE AND DEXAMETHASON; REGISTRATION NO/DATE: EU/1/16/1101 20200122 | ⤷ Start Trial |
| >Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |
